Biotech · Private company
NantCell, Inc.
Track this companyFree. Adds NantCell, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- AMG 479Phase 3 · Adenocarcinoma of the PancreasClinicalTrials.gov · fetched Nov 12, 2026
- gemcitabinePhase 3 · Adenocarcinoma of the PancreasClinicalTrials.gov · fetched Nov 12, 2026
- Ad5 CEA VaccinePhase 2 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- ALT-803Phase 2 · Thyroid CancerClinicalTrials.gov · fetched Nov 12, 2026
- AMG 479Phase 2 · Advanced Squamous Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- AMG 479Phase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- AMG 655Phase 2 · Adenocarcinoma of the PancreasClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 2 · Advanced Squamous Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ETBX-011Phase 2 · Thyroid CancerClinicalTrials.gov · fetched Nov 12, 2026
- GI-6207 [Recombinant Saccharomyces cerevisiae-CEA (610D)]Phase 2 · Medullary Thyroid Cancer (MTC)ClinicalTrials.gov · fetched Nov 12, 2026
- GI-6301 Vaccine (Yeast- Brachyury)Phase 2 · ChordomaClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 2 · Advanced Squamous Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- RadiotherapyPhase 2 · ChordomaClinicalTrials.gov · fetched Nov 12, 2026
- wGT3X-BT ActigraphPhase 2 · ChordomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing CancerPHASE1_PHASE2 · TERMINATED · started Jun 26, 2017ClinicalTrials.gov NCT03127098 · fetched Nov 12, 2026
- QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine ChordomaPHASE2 · COMPLETED · started May 1, 2015ClinicalTrials.gov NCT02383498 · fetched Nov 12, 2026
- QUILT-3.006 for Recurrent Medullary Thyroid CancerPHASE2 · COMPLETED · started Mar 26, 2013ClinicalTrials.gov NCT01856920 · fetched Nov 12, 2026
- QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the PancreasPHASE3 · COMPLETED · started Apr 7, 2011ClinicalTrials.gov NCT01231347 · fetched Nov 12, 2026
- QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEAPHASE1_PHASE2 · COMPLETED · started Jul 16, 2010ClinicalTrials.gov NCT01147965 · fetched Nov 12, 2026
- QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung CancerPHASE1_PHASE2 · TERMINATED · started Jan 1, 2009ClinicalTrials.gov NCT00807612 · fetched Nov 12, 2026
- QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast CancerPHASE2 · COMPLETED · started Mar 27, 2008ClinicalTrials.gov NCT00626106 · fetched Nov 12, 2026
- QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerPHASE1_PHASE2 · COMPLETED · started Jun 1, 2007ClinicalTrials.gov NCT00630552 · fetched Nov 12, 2026